Affiliation: Loyola University Medical Center
- Putative agmatinase inhibitor for hypoxic-ischemic new born brain damageJohn E Piletz
Department of Psychiatry, Stritch School of Medicine, Loyola University Chicago, Loyola University Medical Center, 2160 South First Ave, Maywood, IL 60153, USA
Neurotox Res 24:176-90. 2013..Piperazine-1-carboxamidine therefore appears to be a neuroprotective agent of a new category, agmatinase inhibitor. ..
- Database of genetic studies of bipolar disorderJohn E Piletz
Department of Psychiatry, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois 60153, USA
Psychiatr Genet 21:57-68. 2011..It can serve as the basis for a mega-analysis of candidate genes. Herein, we discuss the most robust and best replicated gene findings to date in a contextual manner...
- AGMATINASE INHIBITORS FOR HYPOXIC-ISCHEMIC NEW BORN BRAIN DAMAGEJohn Piletz; Fiscal Year: 2007..Specific Aim-4 will test which of the compounds is most neuroprotective in rat pups exposed to hypoxia-ischemia. The overall goal of these studies is to develop a treatment for perinatal brain damage in human infants. ..
- TRANSFER OF GRANT - REGULATION OF LIMDAZOLINE SITESJohn Piletz; Fiscal Year: 1993..These studies will answer fundamental questions about the platelet I1 site, its regulation in health and disease and its possible utility as a marker in depressive illness and PMS...
- IMIDAZOLINE RECEPTORS IN DEPRESSION--BASIC STUDIESJohn Piletz; Fiscal Year: 2001..The findings from the clinical grant will best be understood within the context of these studies in the basic grant, and vice versa. ..